Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.
about
The Addictive Model of Self-Harming (Non-suicidal and Suicidal) BehaviorMedications development for opioid abuseNeural mechanisms of pain and alcohol dependenceBehavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.The Human BNST: Functional Role in Anxiety and Addiction.CRF-CRF1 receptor system in the central and basolateral nuclei of the amygdala differentially mediates excessive eating of palatable food.Toward the Identification of a Specific Psychopathology of Substance Use Disorders.Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin.Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.Corticotropin releasing factor: a key role in the neurobiology of addictionPsychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment.Lifelong CRF overproduction is associated with altered gene expression and sensitivity of discrete GABA(A) and mGlu receptor subtypes.Development of mechanical hypersensitivity in rats during heroin and ethanol dependence: alleviation by CRF₁ receptor antagonism.The dark side of food addiction.Stress is a principal factor that promotes tobacco use in femalesStress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity.Antagonism of the neuropeptide S receptor with RTI-118 decreases cocaine self-administration and cocaine-seeking behavior in rats.Motivational Processes Underlying Substance Abuse Disorder.Emerging role for corticotropin releasing factor signaling in the bed nucleus of the stria terminalis at the intersection of stress and reward.Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesisAmygdalostriatal projections in the neurocircuitry for motivation: a neuroanatomical thread through the career of Ann Kelley.Escalation of drug self-administration as a hallmark of persistent addiction liability.Prenatal and gestational cocaine exposure: Effects on the oxytocin system and social behavior with implications for addiction.Addiction and corticotropin-releasing hormone type 1 receptor antagonist medications.Ethanol and corticotropin releasing factor receptor modulation of central amygdala neurocircuitry: An update and future directions.The hijacked brain.Cathepsin H functions as an aminopeptidase in secretory vesicles for production of enkephalin and galanin peptide neurotransmitters.Cyclotides Isolated from an Ipecac Root Extract Antagonize the Corticotropin Releasing Factor Type 1 Receptor.Role of Hypothalamic-Pituitary-Adrenal axis and corticotropin-releasing factor stress system on cue-induced relapse to alcohol seeking.Preclinical metabolism and pharmacokinetics of NVS-CRF38, a potent and orally bioavailable corticotropin-releasing factor receptor 1 antagonist.Social rank-associated stress vulnerability predisposes individuals to cocaine attraction.The Multidimensional Therapeutic Potential of Targeting the Brain Oxytocin System for the Treatment of Substance Use Disorders.Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses.Escalated cocaine "binges" in rats: enduring effects of social defeat stress or intra-VTA CRF.Methamphetamine Induces TET1- and TET3-Dependent DNA Hydroxymethylation of Crh and Avp Genes in the Rat Nucleus Accumbens.Corticotropin-Releasing Factor (CRF) and Addictive Behaviors.Neuropeptide trefoil factor 3 attenuates naloxone-precipitated withdrawal in morphine-dependent mice.Evaluation of Alcohol Preference and Drinking in msP Rats Bearing a Crhr1 Promoter Polymorphism.Early Life Stress Associated With Increased Striatal -Acetyl-Aspartate: Cerebrospinal Fluid Corticotropin-Releasing Factor Concentrations, Hippocampal Volume, Body Mass and Behavioral Correlates
P2860
Q26766469-1D3EE3E2-0336-4EAF-8659-3D48439A904EQ26853370-75C6C567-1F62-42C8-B66E-B52769BF1C30Q26859202-9C636001-ACF0-4A7B-A721-0C674C165C3FQ27014879-0B017002-6746-4C03-BD55-EA802C712A8BQ28081635-4EFA7433-7244-4652-9F6C-FE4361134879Q30551479-99459538-EF24-4ADD-A128-98E0CB9C71DDQ33607241-F4F3EF5B-4DF7-441A-9C84-7E478537C377Q33992170-F76CD1B9-EA0B-4A7A-9895-EE55090EE8E8Q34407185-237BA5D2-E587-49F7-91C7-CD67122565C6Q34421204-5AA1B64C-36A5-46E5-A178-1CEF01AAF180Q34586382-D8C0A535-12CF-4882-BB97-0533AC48E902Q35675641-B8F4B05A-71B2-4E47-85BF-92A9A02B6004Q35685680-29B3DE23-5F60-4E8D-8087-4B1012C7EA46Q35832522-9F9AD581-2F89-4242-83A0-2742F4F3DDE3Q36200563-5F45694F-32BF-4897-9CFC-5CB9D2FF64C6Q36210642-3B16F2D8-C6FC-4CFF-82D7-6BDC78BCFF4DQ36388990-1A5C2268-0A88-46B7-AD1C-80702834EDEBQ36853330-2BF5CFF1-7971-4B35-A448-F896A79910FFQ36881952-B5B19F7B-34C8-4AD0-ACEF-AA722A08A686Q37047922-287F84ED-4E92-4FAF-AA1B-15C4ABB79F4FQ37337326-023ABB09-2B05-4F9A-B946-A9522E0F93EFQ37400689-CECBB5D5-4A8D-44F4-9D38-C3038BE98EF7Q37549425-85637DFB-07AB-48F3-BEC2-6B44289F0347Q38080576-49EF3FB3-F4FA-4945-A47A-E22CB0175F8CQ38365273-D6690E3E-55CB-434B-B886-A2706D9DBE5BQ41645218-B157DCE9-1E77-4AF0-A69F-5D1F63084059Q42147186-0940E173-194E-4FAA-A06F-657BBA0EE88CQ42369922-EBB39C23-D5BD-4051-B640-46B82E3E2CC2Q42393630-1B0F239F-A595-44EC-B844-06C75F50DF4AQ46910443-48CDFF5F-1BCF-4276-B9FD-C6BB85659801Q47552166-B54097F8-2792-4E69-ACD4-35596F6AAE8EQ47681320-BF7546C8-24D3-4FFE-9021-D5F8CF17BDD8Q47706748-D4E00393-DDD0-4E37-87A5-D7EB2219A58EQ47774751-8F4BB4A7-550A-46A7-B68A-EB4EDA6CE571Q47903195-4CB7C79D-FEFD-4CC3-BC24-854327616C57Q48008300-7EEEBBAA-0B43-47F3-87D6-585EFEB21650Q52304648-C3DEEC63-55D4-4FA1-A001-D207FC22AF88Q52315997-C5088B47-20EE-4E62-92CC-9C319B8101BEQ58213863-E0A8FC65-24EB-4CE3-B495-62BFABA21C6F
P2860
Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Role of corticotropin-releasin ...... pharmacological intervention.
@ast
Role of corticotropin-releasin ...... pharmacological intervention.
@en
type
label
Role of corticotropin-releasin ...... pharmacological intervention.
@ast
Role of corticotropin-releasin ...... pharmacological intervention.
@en
prefLabel
Role of corticotropin-releasin ...... pharmacological intervention.
@ast
Role of corticotropin-releasin ...... pharmacological intervention.
@en
P2860
P1433
P1476
Role of corticotropin-releasin ...... pharmacological intervention.
@en
P2093
Eric P Zorrilla
George F Koob
P2860
P304
P356
10.2165/11587790-000000000-00000
P577
2011-04-01T00:00:00Z
P5875
P6179
1011240312